Overview

Vitamin D3 and the Stress-axis in MS

Status:
Terminated
Trial end date:
2016-11-07
Target enrollment:
Participant gender:
Summary
Patients with multiple sclerosis (MS) have an increased risk of developing a major depression. The investigators observed a protective effect of high vitamin D levels on the risk of depression in MS. This might be driven by the effect of vitamin D on the stress-axis. Therefore, the main goal of the present study is to assess whether high dose vitamin D supplementation results in a suppression of the stress-axis, as measured by decreased levels of cortisol.
Phase:
Phase 2
Details
Lead Sponsor:
Academic MS Center Limburg
Treatments:
Cholecalciferol
Ergocalciferols
Vitamin D
Vitamins